Mei Ri Jing Ji Xin Wen·2025-11-06 15:13Core Points - The divorce dispute between Zhao Bingxian, known as "China's Buffett," and his ex-wife Lu Juan has concluded after 15 years, with a court ruling on the division of 1 billion yuan in assets [1][2] - The court's decision mandates an equal split of the shares in Zhongzheng Wanrong Investment Group, which Zhao and Lu held, resulting in each owning 50% of the company [1][3] - Following the ruling, Zhao Bingxian's status as the actual controller of the company has changed, as he previously held 80% of the shares [3][4] Company Overview - Wohua Pharmaceutical, the company involved, specializes in cardiovascular traditional Chinese medicine and has a total market value of 3.556 billion yuan as of November 6 [4] - The company reported a revenue of 625 million yuan for the first three quarters of 2025, reflecting an 8.31% year-on-year increase, and a net profit of 63.995 million yuan, up 179.34% [4] - Wohua Pharmaceutical has 162 drug approval numbers, with 15 exclusive products, and 43 products listed in the National Essential Drug List [4] Historical Context - Zhao Bingxian and Lu Juan founded Zhongzheng Wanrong Group in 1991, initially focusing on investment banking and later expanding into various successful listings [5][6][7][8][9][10][11] - The couple's personal and professional relationship has been tumultuous, marked by allegations of domestic violence and disputes over company assets since Lu filed for divorce in 2010 [1][11]